Target Information

Target General Infomation
Target ID
T49814
Former ID
TTDI01534
Target Name
Bacterial DNA
Target Type
Successful
Disease Amebiasis [ICD9: 6; ICD10: A06]
Blastomycosis [ICD9: 116; ICD10: B40]
Crohn's disease [ICD9: 555; ICD10: K50]
Diarrhea [ICD9: 787.91; ICD10: A09, K59.1]
Drugs and Mode of Action
Drug(s) Clofazimine Drug Info Approved Crohn's disease [538526]
Furazolidone Drug Info Approved Diarrhea [538445]
Hydroxystilbamidine Isethionate Drug Info Approved Blastomycosis [538413]
Metronidazole Drug Info Approved Amebiasis [538506]
Metronidazole Drug Info Phase 3 Crohn's disease [522078]
Modulator Clofazimine Drug Info
Furazolidone Drug Info
Hydroxystilbamidine Isethionate Drug Info
Metronidazole Drug Info
References
Ref 522078ClinicalTrials.gov (NCT00509639) Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease. U.S. National Institutes of Health.
Ref 538413FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 009166.
Ref 538445FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 011270.
Ref 538506FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 018517.
Ref 538526FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 019500.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.